Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy

Recruiting

• Conditions: Brain Metastases, Adult; Primary Brain Tumor; Lung Cancer

• Registration Number: NCT04567251
• Lead Sponsor: Duke University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-9-23
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusion Criteria:<br><br> 1. Cancer survivors who received cranial irradiation including, but not limited to,<br> primary brain tumor, brain metastases, lung cancer receiving prophylactic brain<br> irradiation, long-term survivors of pediatric cancers<br><br> 2. Initial radiation must have been completed more than 6 months prior to enrollment.<br> Acceptable radiation therapies include fractionated partial brain irradiation, whole<br> brain irradiation, or stereotactic radiosurgery (for any modality at least a total<br> cumulative dose of 20 Gy) of at least 20 Gy<br><br> 3. Age = 18 years at the time of entry into the study<br><br> 4. Karnofsky performance score (KPS) = 70 or Eastern Cooperative Oncology Group (ECOG)<br> grade = 2<br><br> 5. No imaging evidence of disease progression within 4 months of enrollment<br><br> 6. Life expectancy > 6 months per treating neuro-oncology providers<br><br> 7. Access to a smartphone, tablet, or computer with capability to utilize the mobile<br> symptom-tracking application<br><br> 8. Subject must be fluent in English<br><br>Exclusion Criteria:<br><br> 1. Active psychiatric illness

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of using a digital symptom tracking application focused on HRQoL and cognition in cancer survivors who received brain irradiation